SciELO - Scientific Electronic Library Online

 
vol.21 issue2Neurological damage in SARS-CoV-2 infectionsMolecular basis of covid-19 pathogenesis and in silico studies of potential pharmacological treatment author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista de la Facultad de Medicina Humana

Print version ISSN 1814-5469On-line version ISSN 2308-0531

Abstract

ABARCA BARRIGA, Hugo Hernán; TRUBNYKOVA, Milana  and  CASTRO MUJICA, María del Carmen. Management of genetic diseases: Present and future. Rev. Fac. Med. Hum. [online]. 2021, vol.21, n.2, pp.399-416. ISSN 1814-5469.  http://dx.doi.org/10.25176/rfmh.v21i2.3626.

Today, the number of genetic diseases is around 10000 conditions, affecting to 6%-8% of all populations. This review shows us how the discovery of genetic variants in our genome, this facilitated to know with precision about the mechanisms physiopathological, and hence to recognize those target points susceptible to modifications, through therapeutical strategies different with palliative proposals, increase life expectancy, or improve qualities of life. These therapies are diverse, using drugs for polygenic diseases, nutritional therapy, special formulas, enzyme replacement therapies, hematopoietic stem cell transplant, substrate reduction, oligonucleotides, and gene therapy. These genetic diseases are heterogeneous clinically with a very low frequency; nevertheless, open to the possibility of research in new strategies for more genetic disease, that today, furthermore, are orphans.

Keywords : diseases; genetic Therapy, hematopoietic Stem Cells, transplant, therapy (Source: MeSH NLM).

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )